Chopas James George 内部人交易：近期 SEC Form 4 交易
过去 18 个月，Chopas James George（CIK 1836430）在 1 家公司共报告 21 笔 SEC Form 4 内部人交易（最近一笔 2026-05-14）。
| 日期 | 公司 | 身份 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-05-14 | Apellis Pharmaceuticals, Inc. (APLS) | VP/Chief Accounting Officer | 买入 | 8,075 | $0 |
| 2026-05-14 | Apellis Pharmaceuticals, Inc. (APLS) | VP/Chief Accounting Officer | 买入 | 5,625 | $0 |
| 2026-05-14 | Apellis Pharmaceuticals, Inc. (APLS) | VP/Chief Accounting Officer | 卖出 | 5,625 | $0 |
| 2026-05-14 | Apellis Pharmaceuticals, Inc. (APLS) | VP/Chief Accounting Officer | 买入 | 8,394 | $0 |
| 2026-05-14 | Apellis Pharmaceuticals, Inc. (APLS) | VP/Chief Accounting Officer | 卖出 | 8,394 | $0 |
| 2026-05-14 | Apellis Pharmaceuticals, Inc. (APLS) | VP/Chief Accounting Officer | 买入 | 16,150 | $0 |
| 2026-05-14 | Apellis Pharmaceuticals, Inc. (APLS) | VP/Chief Accounting Officer | 卖出 | 16,150 | $0 |
| 2026-05-14 | Apellis Pharmaceuticals, Inc. (APLS) | VP/Chief Accounting Officer | 卖出 | 65,955 | $0 |
| 2026-05-14 | Apellis Pharmaceuticals, Inc. (APLS) | VP/Chief Accounting Officer | 卖出 | 8,075 | $0 |
| 2026-05-14 | Apellis Pharmaceuticals, Inc. (APLS) | VP/Chief Accounting Officer | 卖出 | 2,406 | $0 |
| 2026-05-14 | Apellis Pharmaceuticals, Inc. (APLS) | VP/Chief Accounting Officer | 卖出 | 4,156 | $0 |
| 2026-05-14 | Apellis Pharmaceuticals, Inc. (APLS) | VP/Chief Accounting Officer | 卖出 | 9,444 | $0 |
| 2026-05-14 | Apellis Pharmaceuticals, Inc. (APLS) | VP/Chief Accounting Officer | 卖出 | 16,150 | $0 |
| 2026-05-14 | Apellis Pharmaceuticals, Inc. (APLS) | VP/Chief Accounting Officer | 卖出 | 6,250 | $0 |
| 2026-01-30 | Apellis Pharmaceuticals, Inc. (APLS) | VP/Chief Accounting Officer | 买入 | 16,150 | $0 |
| 2026-01-23 | Apellis Pharmaceuticals, Inc. (APLS) | VP/Chief Accounting Officer | 卖出 | 2,064 | $44,933 |
| 2026-01-21 | Apellis Pharmaceuticals, Inc. (APLS) | VP/Chief Accounting Officer | 卖出 | 726 | $14,368 |
| 2026-01-15 | Apellis Pharmaceuticals, Inc. (APLS) | VP/Chief Accounting Officer | 卖出 | 873 | $19,372 |
| 2025-09-17 | Apellis Pharmaceuticals, Inc. (APLS) | VP/Chief Accounting Officer | 卖出 | 189 | $4,572 |
| 2025-09-03 | Apellis Pharmaceuticals, Inc. (APLS) | VP/Chief Accounting Officer | 卖出 | 548 | $15,388 |
| 2025-06-20 | Apellis Pharmaceuticals, Inc. (APLS) | VP/Chief Accounting Officer | 买入 | 6,250 | $0 |
来源：SEC Form 4 申报文件 · 截至 2026-05-14